BEHIND THE NEWS: Another daunting challenge for veteran exec Cornelius
Anyone surprised that at age 62, Jim Cornelius would take on the bruising job of leading embattled drugmaker Bristol-Myers Squibb shouldn’t be. After all, the Zionsville businessman has surprised observers before. This is an executive who 12 years ago gave up one of the top jobs in corporate America-chief financial officer of Eli Lilly and Co.-to become chairman of Guidant Corp., then a much-maligned collection of medical-device firms that Lilly was spinning off into a stand-alone company. A risky move,…